Broët P - Search Results

1

Analyzing cohort studies with interval-censored data: A new model-based linear rank-type test.

Jantzen R, Tubert-Bitter P, Broët P. Jantzen R, et al. Among authors: broet p. Stat Med. 2022 Aug 15;41(18):3479-3491. doi: 10.1002/sim.9429. Epub 2022 May 5. Stat Med. 2022. PMID: 35511124

2

Unobserved covariates in the two-sample comparison of survival times: a maximum efficiency robust test.

Broët P, Moreau T, Lellouch J, Asselain B. Broët P, et al. Stat Med. 1999 Jul 30;18(14):1791-800; discussion 1801. doi: 10.1002/(sici)1097-0258(19990730)18:14<1791::aid-sim215>3.0.co;2-w. Stat Med. 1999. PMID: 10407249 Clinical Trial.

3

A semiparametric approach for the two-sample comparison of survival times with long-term survivors.

Broët P, De Rycke Y, Tubert-Bitter P, Lellouch J, Asselain B, Moreau T. Broët P, et al. Biometrics. 2001 Sep;57(3):844-52. doi: 10.1111/j.0006-341x.2001.00844.x. Biometrics. 2001. PMID: 11550936

4

A score test for establishing non-inferiority with respect to short-term survival in two-sample comparisons with identical proportions of long-term survivors.

Broët P, Tubert-Bitter P, De Rycke Y, Moreau T. Broët P, et al. Stat Med. 2003 Mar 30;22(6):931-40. doi: 10.1002/sim.1453. Stat Med. 2003. PMID: 12627410

5

False discovery rate estimation for frequentist pharmacovigilance signal detection methods.

Ahmed I, Dalmasso C, Haramburu F, Thiessard F, Broët P, Tubert-Bitter P. Ahmed I, et al. Among authors: broet p. Biometrics. 2010 Mar;66(1):301-9. doi: 10.1111/j.1541-0420.2009.01262.x. Epub 2009 May 4. Biometrics. 2010. PMID: 19432790

6

A score test for comparing cross-sectional survival data with a fraction of non-susceptible patients and its application in clinical immunology.

Jonas SF, Mbogning C, Hässler S, Broët P. Jonas SF, et al. Among authors: broet p. PLoS One. 2017 Jun 30;12(6):e0179896. doi: 10.1371/journal.pone.0179896. eCollection 2017. PLoS One. 2017. PMID: 28665947 Free PMC article.

7

A test for comparing current status survival data with crossing hazard functions and its application to immunogenicity of biotherapeutics.

Jonas SF, Mbogning C, Broët P. Jonas SF, et al. Among authors: broet p. Stat Med. 2017 Nov 30;36(27):4364-4377. doi: 10.1002/sim.7439. Epub 2017 Aug 30. Stat Med. 2017. PMID: 28856703

8

Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach.

Duhazé J, Caubet M, Hässler S, Bachelet D, Allez M, Deisenhammer F, Fogdell-Hahn A, Gleizes A, Hacein-Bey-Abina S, Mariette X, Pallardy M, Broët P; ABIRISK Consortium. Duhazé J, et al. Among authors: broet p. BMC Med Res Methodol. 2020 Mar 20;20(1):69. doi: 10.1186/s12874-020-00941-z. BMC Med Res Methodol. 2020. PMID: 32192445 Free PMC article.

9

Quantifying the Predictive Accuracy of a Polygenic Risk Score for Predicting Incident Cancer Cases : Application to the CARTaGENE Cohort.

Duhazé J, Jantzen R, Payette Y, De Malliard T, Labbé C, Noisel N, Broët P. Duhazé J, et al. Among authors: broet p. Front Genet. 2020 Apr 24;11:408. doi: 10.3389/fgene.2020.00408. eCollection 2020. Front Genet. 2020. PMID: 32391062 Free PMC article.

10

Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.

Jantzen R, Payette Y, de Malliard T, Labbé C, Noisel N, Broët P. Jantzen R, et al. Among authors: broet p. BMJ Open. 2021 Apr 12;11(4):e045078. doi: 10.1136/bmjopen-2020-045078. BMJ Open. 2021. PMID: 33846154 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

110 results

Search Page

Filters